NOVE advised sale of 100% Mercurio OÜ shareholding to OneMed

NOVE partner Urmas Volens and lawyer Triin Tiru advised seller in a transaction, resulting in OneMed OÜ, one of the leading medical products distributors in Northern Europe, acquiring 100% ownership of Mercurio OÜ.

Mercurio operates in the Baltics mainly as a distributor of ResMed sleep apnea equipment and accessories since 2011 and has become the market leader in the industry due to its great effort and smart operating. Mercurio manages networked innovative medical data systems and medical devices web store In addition to distributing ResMed equipment and accessories, Mercurio is also Baltic partner to Nox Medical, the world’s leading developer and manufacturer of respiratory diagnosis devices, and Nonin, the world’s leading developer and manufacturer of pulse oximetry equipment.

According to OneMed, who acquired the sole ownership in Mercurio, “OneMed OÜ is honored to lead such exemplary company to its further development phase. From the point of view of OneMed’s expansion and development, this step is of strategic importance, and the promotion of similar views and values in the field of medical supplies is also very important. The activities of Mercurio OÜ so far continue in the same spirit, with the desire to ensure smooth communication and convenient service for all patients and partners.”

NOVE’s advice included drafting transaction documents as well as supporting the client in conducting a legal audit, negotiating, and dealing with any legal issues that arose in connection with the transaction. In the areas of activity of NOVE, the transaction covered M&A, General Contract Law, Data Protection and Medical Law. Founded in 2016, NOVE is a fast-growing new-generation law firm that, in addition to its specialization in litigation, has expanded its business to include M&A, real estate, company law, data protection, medical law and competition law.